Viewing Study NCT00417820


Ignite Creation Date: 2025-12-25 @ 4:14 AM
Ignite Modification Date: 2026-05-10 @ 6:56 AM
Study NCT ID: NCT00417820
Status: COMPLETED
Last Update Posted: 2007-11-29
First Post: 2007-01-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of the Safety, Tolerability and Efficacy of BCT194 in Healthy Volunteers and Patients With Psoriasis.
Sponsor: Novartis
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Psoriasis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Safety, tolerability, pharmacodynamics, single administration, BCT194, healthy volunteers, psoriasis View